You just read:

Vascular Dynamics, a Part of the Rainbow Medical Investment Cluster, Received FDA Approval to Begin Conclusive and Pivotal Trial Experimentation for Their Flagship Product Designed to Treat Chronic Hypertension

News provided by

Vascular Dynamics and Rainbow Medical

22 Aug, 2017, 02:00 BST